Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Yes — there is an active recall. 3 ongoing FDA recalls mention Oxytocin (76 total). Check the affected lots below.
Most common reason: Sterility / contamination (46 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Oxytocin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Lack of Assurance of Sterility
cGMP violations
Labeling: Not Elsewhere Classified
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.